HongYue Dai

Title: Innovations and Contributions of Inventor HongYue Dai

Introduction

HongYue Dai is a prominent inventor based in Bothell, WA (US). He has made significant contributions to the field of cancer research, particularly in the diagnosis and prognosis of breast cancer. With a total of 9 patents to his name, Dai's work has had a profound impact on medical science.

Latest Patents

One of his latest patents focuses on the diagnosis and prognosis of breast cancer patients. This invention relates to genetic markers whose expression is correlated with breast cancer. Specifically, it provides sets of markers whose expression patterns can be used to differentiate clinical conditions associated with breast cancer, such as the presence or absence of the estrogen receptor ESR1, and BRCA1 and sporadic tumors. The invention also offers information on the likelihood of tumor distant metastases within five years of initial diagnosis. Furthermore, it includes methods for using these markers to distinguish these conditions, as well as kits containing ready-to-use microarrays and computer software for data analysis using the disclosed statistical methods.

Another notable patent by Dai is a method and computer program product for reducing fluorophore-specific bias. This method addresses fluorophore bias removal in microarray experiments by reversing the fluorophores used in microarray experiment pairs. It also calculates the individual errors associated with each measurement made in nominally repeated microarray experiments. This error measurement can be coupled with rank-based methods to determine the probability that a cellular constituent is up or down regulated in response to a perturbation. Additionally, it provides a method for determining the confidence in the weighted average of the expression level of a cellular constituent in nominally repeated microarray experiments.

Career Highlights

Throughout his career, HongYue Dai has worked with notable organizations such as Rosetta Inpharmatics, Inc. and The Netherlands Cancer Institute. His experience in these institutions has contributed to his expertise in cancer research and innovation.

Collaborations

Dai has collaborated with esteemed colleagues, including Yudong He and Peter S. Linsley. These partnerships have further enhanced his research and development efforts in the field.

Conclusion

In summary, HongYue Dai is a distinguished inventor whose work in cancer research has led to significant advancements in the diagnosis and prognosis of breast cancer. His innovative patents and collaborations reflect his commitment to improving medical science and patient outcomes.